Founded by Yale professors Akiko Iwasaki and Anna Marie Pyle, RIGImmune has announced its launch, an acquisition and a financing all in a single day. 15 September 2022
Belgian cell therapy company Bone Therapeutics is to acquire a majority stake in Medsenic, a privately-held French biopharma specializing in the development of 10 August 2022
Cash-rich pharma giant Pfizer is continuing its spending spree, with the $5.4 billion acquisition of rare blood disease specialist Global Blood Therapeutics. 8 August 2022
Dutch firm NewAmsterdam Pharma Holding and Frazier Lifesciences Acquisition Corporation, a special purpose acquisition company (SPAC) sponsored by an affiliate 26 July 2022
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news